A look back at the week's news.
Researchers have found that maternal antenatal corticosteroid treatment can lead to increased risk of psychological developmental and neurosensory disorders in children.
More women are using medical cannabis for menopause-related symptoms, according to research recently published in Menopause.
Trigger bans took effect on Thursday, August 25, 2022, in Tennessee, Idaho, and Texas, banning abortion from conception in Tennessee and Idaho and enacting harsher penalties for providers in Texas.
Take a look back at our most popular stories from August 2022.
Marina Sirota, PhD, associate professor of pediatrics at the University of California, San Francisco, spoke about the new March of Dimes Prematurity Research Center at UCSF and the impact they hope their research will have on the future of preterm birth.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More